Related Experiment Videos
Postoperative nausea and vomiting in the plastic surgery patient
Robert Lee Steely1, Donald R Collins, Benjamin E Cohen
1Houston, TX 77002, USA.
Aesthetic Plastic Surgery
|April 30, 2004
Summary
This study identified risk factors for postoperative nausea and vomiting (PONV) in plastic surgery patients. A novel prophylactic antiemetic regimen significantly reduced PONV incidence from 22% to 3%.
Area of Science:
- Anesthesiology
- Plastic Surgery
- Pharmacology
Background:
- Postoperative nausea and vomiting (PONV) remains a significant challenge in modern medicine, lacking a definitive cure.
- Identifying specific risk factors in plastic surgery is crucial for targeted prevention strategies.
Purpose of the Study:
- To identify preoperative risk factors for PONV in plastic surgery patients.
- To evaluate a prophylactic antiemetic regimen for reducing PONV incidence.
Main Methods:
- Prospective study of 143 plastic surgery patients (1998-2000).
- Analysis of preoperative risk factors.
- Implementation and assessment of a multi-agent antiemetic prophylactic regimen.
Main Results:
- A specific prophylactic regimen was identified.
- The incidence of PONV decreased dramatically from a published 22% to 3% with the regimen.
- The regimen included ondansetron, promethazine, metoclopramide, and dexamethasone in select cases.
Conclusions:
- Preoperative risk factor identification is key for PONV management in plastic surgery.
- A multi-agent antiemetic prophylactic regimen is highly effective in reducing PONV.
- This approach offers a significant improvement over existing treatments for PONV.